Your session is about to expire
← Back to Search
Semantic Feature Analysis Treatment for Aphasia
N/A
Recruiting
Led By William D Hula, Ph.D.
Research Sponsored by VA Pittsburgh Healthcare System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No participation in any other speech-language treatment during this study, including follow-up period
6 months post-onset of aphasia due to unilateral left-hemisphere (LH) stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up (1) 1 week prior to intervention; (2) immediately prior to intervention; (3) 1-2 days post intervention (4) 8 to 12 weeks post intervention
Awards & highlights
Study Summary
This trial is studying two different versions of an existing treatment for naming impairments in aphasia, to see which one is more effective. It will also look at the brain and cognitive processes behind why one treatment works better than the other.
Who is the study for?
This trial is for individuals who have aphasia due to a stroke in the left side of their brain, at least 6 months ago. They must be able to manage daily activities on their own or with help from a caregiver, and not have uncontrolled health issues like seizures. Participants should speak English as their first language and not be involved in other speech treatments during the study.Check my eligibility
What is being tested?
The study tests two versions of Semantic Feature Analysis treatment for naming impairments caused by aphasia. It's a randomized controlled trial where participants are assigned randomly to one of the two treatment groups to see which is more effective.See study design
What are the potential side effects?
Since this trial involves speech-language therapy, there aren't typical medical side effects; however, participants may experience fatigue or frustration during intensive therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am not participating in any other speech therapy during this study.
Select...
It's been 6 months since my stroke, which caused speech issues.
Select...
I can do daily tasks by myself or have someone to help me.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ (1) 1 week prior to intervention; (2) immediately prior to intervention; (3) 1-2 days post intervention (4) 8 to 12 weeks post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~(1) 1 week prior to intervention; (2) immediately prior to intervention; (3) 1-2 days post intervention (4) 8 to 12 weeks post intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Confrontation Naming
Secondary outcome measures
Aphasia Communication Outcome Measure (ACOM)
Comprehensive Aphasia Test
Magnetic Resonance Imaging
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SFA Experimental InterventionExperimental Treatment1 Intervention
A modified version of Semantic Feature Analysis will be administered.
Group II: SFA Active Comparator InterventionActive Control1 Intervention
A standard version of Semantic Feature Analysis will be administered.
Find a Location
Logistics
Travel, including flights, are covered
Your expenses for travel tickets for this trial will be reimbursed.
Who is running the clinical trial?
VA Pittsburgh Healthcare SystemLead Sponsor
32 Previous Clinical Trials
11,369 Total Patients Enrolled
Penn State UniversityOTHER
355 Previous Clinical Trials
125,717 Total Patients Enrolled
1 Trials studying Aphasia
19 Patients Enrolled for Aphasia
William D Hula, Ph.D.Principal InvestigatorVA Pittsburgh Healthcare System
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a serious mental health condition.I am not participating in any other speech therapy during this study.It's been 6 months since my stroke, which caused speech issues.You have shown enough trouble with naming things during the screening.You are currently dependent on drugs or alcohol.You have a serious problem with speaking or moving.I had a stroke in the right side of my brain.I have a neurological condition that is not a stroke.I can do daily tasks by myself or have someone to help me.
Research Study Groups:
This trial has the following groups:- Group 1: SFA Experimental Intervention
- Group 2: SFA Active Comparator Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants has this research attracted thus far?
"Affirmative, the data on clinicaltrials.gov indicates that this medical research is currently enrolling patients. The trial was posted to the website in February of 2020 and has been revised as of January 14th 2022. This particular experiment requires 40 participants from a single site."
Answered by AI
Are researchers still recruiting subjects for this trial?
"The clinical trial is actively enrolling patients, according to the reports on clinicaltrials.gov. The study was initially published on February 24th 2020 and it underwent its most recent update 14 months later in January 2022."
Answered by AI
Recent research and studies
Popular Categories
Share this study with friends
Copy Link
Messenger